Chronic ICV administration of oxyntomodulin, a GLP-1R agonist, in mice decreased body weight despite having no significant effects on food intake (Lockie et al., 2012)
In our gut, this binding increases insulin levels and reduces blood sugar levels
hazard ratio 0.71, 0.52 to 0.98), whereas serious renal events generated a wide confidence interval (1.4 v 2.0 events per 1000 person years
Effects of a growth hormonereleasing hormone analog on endogenous GH pulsatility and insulin sensitivity
News & Blogs Stay connected through our latest news, blogs, and upcoming events
Amylin receptor activation in the ventral tegmental area reduces motivated ingestive behavior